#kras — Friday, September 11, 2026 (1 items)
| 0 | ℹ |
Mutant p53 sensitizes KRAS-driven lung adenocarcinoma to immunotherapy by repressing SPP1.
(science.org)
|
Science Advances 2026-09-11 | #immunotherapy #adenocarcinoma #tumor immunity #checkpoint-blockade #kras |